Yanlin Han
Gründer bei Shanxi Tongling Pharmaceutical Co.
Profil
Yanlin Han is the founder of Shanxi Tongling Pharmaceutical Co., which was founded in 1994.
He is currently the Chairman & President of Dragon Pharmaceutical, Inc., the Chairman of Oriental Wave Holding Ltd., and the Vice President of both Shanxi Province Foreign Investment Enterprise Association and Datong City Trade Council.
Mr. Han obtained his undergraduate degree from Shanxi University of Finance & Economics in 1986.
Aktive Positionen von Yanlin Han
| Unternehmen | Position | Beginn |
|---|---|---|
Dragon Pharmaceutical, Inc.
 Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Vorsitzender | 12.01.2005 |
| Shanxi Province Foreign Investment Enterprise Association | Corporate Officer/Principal | - |
| Datong City Trade Council | Corporate Officer/Principal | - |
Oriental Wave Holding Ltd.
 Oriental Wave Holding Ltd. Pharmaceuticals: MajorHealth Technology Part of Datong Investment, Inc., Oriental Wave Holding Ltd. develops pharmaceuticals. Oriental Wave Holding was acquired by Dragon Pharmaceutical, Inc., part of Datong Investment, Inc. from July 22, 2010 on January 12, 2005. | Vorsitzender | - |
| Shanxi Tongling Pharmaceutical Co. | Gründer | 28.04.2011 |
Ausbildung von Yanlin Han
| Shanxi University of Finance & Economics | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
Oriental Wave Holding Ltd.
Oriental Wave Holding Ltd. Pharmaceuticals: MajorHealth Technology Part of Datong Investment, Inc., Oriental Wave Holding Ltd. develops pharmaceuticals. Oriental Wave Holding was acquired by Dragon Pharmaceutical, Inc., part of Datong Investment, Inc. from July 22, 2010 on January 12, 2005. | Health Technology |
| Shanxi Province Foreign Investment Enterprise Association | |
| Datong City Trade Council | |
| Shanxi Tongling Pharmaceutical Co. |
